Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMEGA: EFA Esters in Cardiovascular Disease Prevention
NCT04743050Phase 3Unknown
- Sponsor
- Wroclaw Medical University
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Alpha-linolenic acid in cardiovascular diseases (CVD), sponsored by Wroclaw Medical University. Status: unknown.
02
Drugs
Alpha-linolenic acid
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT04743050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04743050.